KINNATE BIOPHARMA INC - COM (KNTE)

Historical Portfolio Holders from Q4 2020 to Q1 2024

All holders as of March 31, 2024
Q1 2024
Type / Class
Equity / COM
Shares, excl. options Q1 2024
34.6 M
Holdings value Q1 2024
$92 M
Value change Q1 2024
-$9.03 M
Grand Portfolio weight change Q1 2024
0%
Number of holders
51
Number of buys Q1 2024
23
Number of sells Q1 2024
-38
Average buys Q1 2024 %
+0%
Average sells Q1 2024 %
-0.001%
CUSIP
49705R105
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
Period Shares, Excl. Options Value, Excl. Options Change Price Investors
2024 Q1 34.6 M $92 M -$9.03 M $2.66 51
2023 Q4 38.4 M $91 M +$3.84 M $2.37 60
2023 Q3 38.5 M $53.9 M -$5.47 M $1.40 53
2023 Q2 40.1 M $121 M -$32.3 M $3.03 69
2023 Q1 43.3 M $270 M +$15.3 M $6.25 70
2022 Q4 40.8 M $249 M -$18.3 M $6.10 78
2022 Q3 43.5 M $520 M +$5.55 M $11.95 77
2022 Q2 43 M $543 M +$23.3 M $12.61 69
2022 Q1 41.3 M $465 M -$24.8 M $11.26 73
2021 Q4 42.3 M $750 M +$367 K $17.72 68
2021 Q3 36.6 M $842 M +$23.4 M $23.02 69
2021 Q2 38.3 M $891 M +$7.68 M $23.28 61
2021 Q1 35.1 M $1.09 B +$51.8 M $31.16 61
2020 Q4 33.1 M $1.31 B +$1.28 B $39.78 53